Avient (AVNT) Stock Looks Undervalued On Cash Flow But Fair On Earnings
Avient stock has logged a strong move year to date, yet the valuation picture is mixed, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model suggesting the shares trade at a meaningful discount while market based multiples look closer to fair.
- Year to date, Avient is up 37.5%, which puts recent price momentum firmly on the positive side before any valuation checks are applied.
- Expectations around Avient's ability to convert revenue into steady cash flow can support the current share price. However, any pressure on margins or weaker cash generation may limit how much value investors are willing to ascribe.
- Across broader valuation checks, Avient scores 3 out of 6, which points to a mixed picture rather than a clear bargain or clear overvaluation.
The issue now is whether Avient's share price already reflects most of the value suggested by the intrinsic estimate or if the current discount still offers room for upside.
Scan for other potential Avient style opportunities by weighing its DCF gap and mixed value score against 54 high quality undervalued stocks with similar cash flow strength and balance sheet quality.
Is Avient Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) model for Avient focuses on the cash the business can return to shareholders over time. In this view, Avient is valued based on its ability to keep converting revenue into free cash flow.
The model uses last twelve month free cash flow of about $181.7 million and projects growing cash flows over time. Under these assumptions, the DCF model estimates an intrinsic value of about $64.58 per share, which is higher than the current share price. That difference suggests the stock is trading at a 32.5% discount to this cash flow based estimate.
On this Discounted Cash Flow view, Avient stock currently appears undervalued.
Our Discounted Cash Flow (DCF) analysis suggests Avient is undervalued by 32.5%. Track this in your watchlist or portfolio, or discover 54 more high quality undervalued stocks.
Is Avient Fairly Priced on Earnings?
The P/E ratio suits Avient because earnings remain a core reference point for how the market prices the stock. Avient currently trades on a P/E of about 23.5x, which is close to the Chemicals industry average of roughly 23.0x and below the peer group average of about 30.9x. That indicates the market is not assigning an aggressive premium to Avient relative to other earnings-generating stocks in the sector.
The Fair P/E Ratio for Avient is estimated at about 22.5x based on factors such as its industry, profitability profile, size, and risk. The current 23.5x multiple sits only slightly above this level, which suggests the market is pricing the stock in line with those fundamentals rather than at a clear discount or a clear premium.
On the P/E multiple, Avient stock appears roughly fairly valued compared with both its tailored fair ratio and the wider Chemicals sector.
See what the numbers say about this price — find out in our valuation breakdown.
The Avient Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where this Avient valuation puzzle leaves off. They spell out which assumptions about Avient's future growth, margins and earnings would need to hold for the stock to be worth significantly more or less than today's price, all housed on the Community page. Each narrative links a fair value estimate to a specific storyline about Avient's potential catalysts and risks, so you can track over time which scenario is closest to what actually occurs.
The Avient community is split between a margin and mix driven rerating story and a view that most of that optimism is already in the price.
Bull case: 22% undervalued
"Productivity programs in sourcing, plant footprint, Lean Six Sigma and simplified structure delivered about US$40 million of net productivity in 2025 with a portion carrying into 2026 and further actions underway…"
Read the full Bull Case to see why Avient could be undervalued
Bear case: roughly fairly valued
"Although growth vectors such as health care, defense and materials tied to artificial intelligence and data center buildout are gaining traction, they currently offset weakness in roughly 80% of the portfolio rather than driving broad-based expansion…"
Read the full Bear Case to see why Avient could be overvalued
Do you think there's more to the story for Avient? Head over to our Community to see what others are saying!
The Bottom Line
For Avient, the Discounted Cash Flow (DCF) estimate points to a meaningful intrinsic value gap, while the P/E based view sits much closer to about right. That mix leaves the stock looking neither like a clear bargain nor obviously stretched. The key question is whether Avient can sustain cash generation and margins strongly enough for the intrinsic value case to hold. If those assumptions do not play out, the current pricing on earnings is likely to define the outcome more than the headline DCF discount.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com